HIV-1 drug resistance in people on dolutegravir-based ART: Collaborative analysis of cohort studies

Tom Loosli, Stefanie Hossmann, Suzanne M. Ingle, Hajra Okhai, Katharina Kusejko, Johannes Mouton, Pantxika Bellecave, Ard van Sighem, Melanie Stecher, Antonella d’Arminio Monforte, M. John Gill, Caroline A. Sabin, Gary Maartens, Huldrych F. Günthard, Jonathan A. C. Sterne, Richard Lessells, Matthias Egger, Roger Kouyos
doi: https://doi.org/10.1101/2023.04.05.23288183

Article Information

doi 
https://doi.org/10.1101/2023.04.05.23288183
History 
  • April 5, 2023.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.

Author Information

  1. Tom Loosli1,2,
  2. Stefanie Hossmann3,
  3. Suzanne M. Ingle4,
  4. Hajra Okhai5,
  5. Katharina Kusejko1,2,
  6. Johannes Mouton6,
  7. Pantxika Bellecave7,
  8. Ard van Sighem8,
  9. Melanie Stecher9,10,
  10. Antonella d’Arminio Monforte11,
  11. M. John Gill12,13,
  12. Caroline A. Sabin5,
  13. Gary Maartens6,
  14. Huldrych F. Günthard1,2,
  15. Jonathan A. C. Sterne4,
  16. Richard Lessells15,16,*,
  17. Matthias Egger3,4,16,*,† and
  18. Roger Kouyos1,2,*
  1. 1Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland
  2. 2Institute of Medical Virology, University of Zurich, Zurich, Switzerland
  3. 3Institute of Social and Preventive Medicine (ISPM), University of Bern, Switzerland
  4. 4Population Health Sciences, Bristol Medical School, University of Bristol, UK
  5. 5Institute for Global Health, University College London, UK
  6. 6Department of Medicine, University of Cape Town, Cape Town, South Africa
  7. 7Virology laboratory, University Hospital Bordeaux, Bordeaux, France
  8. 8Stichting hiv monitoring, Amsterdam, the Netherlands
  9. 9German Center for Infection Research (DZIF), Partner-Site Cologne-Bonn, Cologne, Germany
  10. 10University of Cologne, Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf
  11. 11Italian Cohort Naive Antiretrovirals, (ICONA) L’Azienda Socio Sanitaria Territoriale (ASST) Santi Paolo e Carlo, Milano, Italy
  12. 12Southern Alberta Clinic, Calgary, AB, Canada
  13. 13Department of Medicine, University of Calgary, Calgary, AB, Canada
  14. 14KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), University of KwaZulu-Natal, Durban, South Africa
  15. 15Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa
  16. 16Centre for Infectious Disease Epidemiology and Research, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa
  1. ↵†Correspondence to: Prof Matthias Egger MD; matthias.egger{at}ispm.unibe.ch

  1. ↵* Authors contributed equally

Back to top
Posted April 05, 2023.
Download PDF

Supplementary Material

Data/Code
Email
HIV-1 drug resistance in people on dolutegravir-based ART: Collaborative analysis of cohort studies
Tom Loosli, Stefanie Hossmann, Suzanne M. Ingle, Hajra Okhai, Katharina Kusejko, Johannes Mouton, Pantxika Bellecave, Ard van Sighem, Melanie Stecher, Antonella d’Arminio Monforte, M. John Gill, Caroline A. Sabin, Gary Maartens, Huldrych F. Günthard, Jonathan A. C. Sterne, Richard Lessells, Matthias Egger, Roger Kouyos
medRxiv 2023.04.05.23288183; doi: https://doi.org/10.1101/2023.04.05.23288183
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area